Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Astrana Health (ASTH)

Astrana Health: Chief Accounting Officer Glenn Sobotka to retire August 7, 2026

Neutral Impact 2 of 5 leadership Written later

Astrana Health said its Chief Accounting Officer and principal accounting officer, Glenn Sobotka, will retire effective August 7, 2026, with the company saying the decision does not reflect any disagreement on operations, policies, or practices. John Vong, previously the company's Group Vice President, Accounting, will succeed him as principal accounting officer on that date. The change is administrative in nature and does not alter reported financial results.

Key points

  • Glenn Sobotka retires as Chief Accounting Officer effective August 7, 2026; the agreement was reached June 25, 2026
  • John Vong becomes Senior Vice President, Accounting effective July 1, 2026, and principal accounting officer on August 7, 2026
  • Vong's annual base salary rises to $320,000 effective July 1, 2026; his 2026 target bonus percentage is unchanged

The filing

CompanyAstrana Health (ASTH)
Form8-K, current report
Filed with the SECJul 1, 2026, 4:15 PM ET
Accession number0001104659-26-079874

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:54 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 01, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.